Morphine is a powerful opioid pain reliever used primarily to manage severe pain when other treatments aren’t enough. It remains one of the most widely used medications in hospitals, surgical recovery, cancer care, and end-of-life settings. Beyond pain, morphine also plays an important role in relieving severe shortness of breath in patients with advanced illness.
Severe Pain Management
The core use of morphine is treating pain that is severe enough to require an opioid and hasn’t responded to milder options like acetaminophen, ibuprofen, or combination painkillers. In practice, this covers a wide range of situations: recovery from major surgery, traumatic injuries like broken bones or burns, kidney stones, and pain from advanced cancer.
Morphine is generally reserved as a second or third option rather than a first-line treatment. The FDA label is explicit on this point: it should only be used when non-opioid alternatives have failed, aren’t tolerated, or aren’t expected to work. If the pain improves enough that a weaker medication could handle it, the expectation is to transition off morphine rather than continue indefinitely.
Cancer and Chronic Pain
For people living with cancer, morphine is often central to pain control. Tumors can press on nerves, invade bone, or cause pain that persists around the clock. In these cases, extended-release morphine tablets provide steady pain relief over 12 hours, while immediate-release doses handle sudden flares of pain that break through the baseline medication. This combination of a long-acting foundation with short-acting rescue doses is a standard approach in cancer pain management.
Outside of cancer, morphine is sometimes used for chronic pain from other causes, but guidelines are more cautious here. The risks of tolerance (needing higher doses over time) and physical dependence make long-term use a careful balancing act, and clinicians typically exhaust other strategies first.
Breathing Difficulty in Advanced Illness
One of morphine’s lesser-known but critically important uses is relieving severe shortness of breath, particularly in patients near the end of life. When someone with advanced heart failure, COPD, or terminal cancer struggles to breathe and standard treatments have stopped working, low-dose morphine can significantly ease that distressing sensation.
Opioids are considered the treatment of choice for end-of-life breathlessness. For someone who hasn’t taken opioids before, oral doses of 5 mg or less often provide noticeable relief. When breathing difficulty comes on suddenly and severely, intravenous morphine works faster. The medication doesn’t improve lung function itself. Instead, it changes how the brain processes the sensation of air hunger, reducing the feeling of suffocation and the panic that comes with it.
This use sometimes causes concern among family members who worry that morphine will hasten death. At the low doses used for breathlessness, the goal and effect is comfort, not sedation.
Heart Attack Pain Relief
Morphine has a long history of use during heart attacks, though its role has become more nuanced. The 2025 guidelines from the American College of Cardiology and the American Heart Association still include morphine as an option for chest pain during a heart attack, but only when other treatments like nitroglycerin have been maximized and pain persists.
The concern is twofold. First, morphine can slow the absorption of other critical medications taken by mouth, particularly blood thinners that need to act quickly during a heart attack. Second, using morphine to mask ongoing chest pain could delay the recognition that a patient needs an emergency procedure to reopen a blocked artery. The current guidance is clear: morphine can help with pain control, but it shouldn’t be used as a substitute for fixing the underlying blockage.
How Morphine Is Given
Morphine comes in several forms, and the choice depends on the situation. In hospitals and emergency rooms, it’s typically given by injection, either into a vein or under the skin. Intravenous morphine acts within minutes, which makes it the go-to option for acute pain or sudden breathing crises. For patients who need continuous relief, a pump can deliver a steady dose with the option to press a button for extra medication during pain spikes.
For ongoing use outside the hospital, morphine comes as oral tablets and liquid. Immediate-release forms start working within about 30 minutes, with effects lasting roughly four hours. Extended-release tablets take longer to kick in (around 1.5 hours to reach the same blood levels that immediate-release hits in 30 minutes) but provide smoother, more consistent relief. The tradeoff is straightforward: extended-release versions avoid the peaks and valleys of short-acting doses, which means fewer moments of breakthrough pain and less frequent dosing.
Common Side Effects
Morphine’s side effects are predictable and largely shared across all opioid medications. The most common ones include constipation, drowsiness, and nausea.
- Constipation is nearly universal with regular use and, unlike most other side effects, doesn’t improve over time. The body doesn’t develop tolerance to morphine’s effect on the gut. Most people on ongoing morphine need a laxative from the start.
- Drowsiness is common when first starting morphine or after a dose increase. It typically fades after a few days as the body adjusts, but it can impair driving and concentration in the meantime.
- Nausea affects some people, especially early on. It also tends to diminish within the first week of use.
At higher doses or in sensitive individuals, morphine can slow breathing. This is the most dangerous side effect and the primary risk in overdose situations. Older adults and people with kidney or liver problems process morphine more slowly, which means the drug can build up to higher-than-expected levels. Dosing for these groups starts lower and increases cautiously.
Risk of Dependence and Addiction
Physical dependence develops in virtually anyone who takes morphine regularly for more than a few weeks. This means stopping suddenly causes withdrawal symptoms like sweating, muscle aches, anxiety, and insomnia. Physical dependence is a normal physiological adaptation, not the same thing as addiction.
Addiction, which involves compulsive use despite harm, is a separate risk. It can develop at any dose or duration, though the risk is higher in people with a personal or family history of substance use disorders. For patients using morphine as prescribed for genuine pain, especially in cancer or end-of-life care, addiction rates are considerably lower than in recreational use. Still, the risk is real enough that prescribers weigh it carefully before starting morphine and monitor throughout treatment.
Who Should Avoid Morphine
Morphine is not safe for everyone. People with significant breathing problems, such as severe asthma or respiratory failure, face heightened risk because morphine further suppresses the drive to breathe. It’s also contraindicated in people with a known bowel obstruction, since it slows gut movement and could worsen the blockage.
People with kidney impairment need special caution. The body breaks morphine down into metabolites that are cleared by the kidneys, and when kidney function is reduced, these metabolites accumulate and can cause excessive sedation or breathing problems. Liver disease similarly affects how the body processes the drug. In both cases, lower starting doses and careful monitoring are essential rather than avoiding morphine entirely, since sometimes no good alternative exists for the level of pain involved.